The market for Topical Pain Killers is expected to grow at a CAGR of around 6.24% from 2020 to 2027 and expected to reach the market value of around US$ 12,273 Mn by 2027.
Topical pain killers are medications that are directly applied to the epidermal layer of skin or at the inflammatory site. Topical pain killers are designated only for pain relief and use the skin as a medium that has an onset directly on the targeted sites through subcutaneous route of administration. Topical pain killers involve high amount of analgesics. These analgesics are incorporated in the form of non-steroidal anti-inflammatory drugs, capsaicin, anesthetics, ketamine, clonidine, cannabinoids, and opioids. Topical pain killers have the ability to dissolve directly in the bloodstream slowly and gradually keeping the blood level constant. It has achieved wide popularity over the years as it is a good alternative for the patients unable to administer orally. These are available as over-the-counter (OTC) products while others are sold by prescriptions only.
As per the Centers for Disease Control and Prevention (CDC) in 2016, an estimated 20.4% of the US adults (50.0 million) patient pool suffered from chronic pain. In addition, 8.0% of the US adults had suffered from high-impact chronic pain associated with advancing age. Such high prevalence of chronic pain and age associated pain was witnessed higher among women. Rise in awareness among the patients regarding the faster and sustained effect by topical pain relief medication and rising geriatric population raising the demand for topical pain relief products drives the topical pain killers market globally.
Market Dynamics
High prevalence of patient pool suffering from arthritis and bone related disorders boosts the topical pain killers market. One of the preliminary factors that are responsible for driving the market growth for topical pain killers involves selling of OTC as an alternative for the prescribed products by the physicians. As topical pain killer medicines are available in the form of OTC sold conveniently at retail outlets they have the ability to take a strong lead in the market and maintain its momentum till the forecast period.
For instance, the statistics released by Consumer Cream Product Association (CHPA), the demand for OTC medicines rise from USD 33.1 billion to USD 32.2 billion from 2018-2019. Moreover, there is a paradigm shift towards the utility of OTC medicines from the rising patient pool suffering from pain related disorders; the prescription medicines related to pain disorders have switched to affordability options for the patients. This further fuels the market growth for topical pain killers. As per the CHPA, there is a total of 2.9 billion retail trips annually to purchase OTC products.
On the other hand, 20 percent of the children aged 8 to 12 and 45 percent of those aged 13 to 14 suffer from arm pain as per the statistics released by STOP Sports Injuries. In US around 21% of traumatic brain injuries are caused due to sports and recreational activities. This further spur the demand for topical pain killers that results in driving market growth.
Sale of topical pain killers through online platforms has gained a significant attention in the overall market to grow. These have a significant effect with lucrative opportunities for the overall market to grow worldwide. However, factors such as topical pain killers causing irritated skin coupled with strong odor and unpleasant smell will restrain the market to grow.
OTC platform: Top Investment Pocket
The OTC derivatives market has grown dramatically over the years as numerous unique products are traded on OTC markets by the manufacturers. The improvement in topical formulations which can have better effect at the inflammatory sites and pharmaceutical sales improvement has grabbed huge attention in the worldwide market. This created lucrative opportunities for companies to sell medicines online. Better convenience or access to medicines greater the sales turnover can be achieved. Among the currencies for the OTC market in emerging market economies (EMEs), “renminbi-denominated contracts” were the most actively traded deal of USD 33 billion as of in April 2019 that is 0.5% of the global turnover. This is followed by Korean Won at USD 27 billion per that is 0.4%.
Segmental Analysis
The global topical pain killers market is segmented as Type, Formulation, Therapeutic class, and Distribution Channel. Based on therapeutic class, the market is bifurcated into non-opioids and opioids. The non-opioids segment is further sub-segmented into NSAIDs, capsaicin, lidocaine, methyl salicylate, among others. The opioids segment is further classified into fentanyl and buprenorphine. In 2017, non-opioids segmented acquired the largest market and is expected to continue this trend in the forthcoming years owing to high demand from the market for the prolonged effect and high availability at the stores. As NSAIDs are successful for reducing the pain by 50% or more in 6 out of 10 patients and it has high demand from the patient pool suffering from the pain. In addition, there is a high demand from the topical treatments by the athletes facing sports injury. With new product development procedures and formulation techniques, it is creating new pathway for the research and development activities.
On the basis of type, topical pain killers market is classified as prescription pain relief and over the counter (OTC) relief. Over the counter relief has grabbed highest market share in the past due to easy availability of the medicines on-stores and high demand for topical pain killers by the sports person. Formulation is segmented as cream, spray, gel, patch, and others. Cream-based topical pain killers accounted for largest sales turnover in the past and will continue to achieve high turnover in the forthcoming years owing to high success rate and lesser side effects associated with the products in the market.
Regional Landscape
Based on the regions, the regional market is segmented as Europe, North America, the Middle East & Africa, Latin America, and Asia Pacific.
Based on the regions, North America leads the global topical pain killer’s market owing to high awareness regarding the adverse effects associated with systemic administration of drugs. Rising number of people suffering from migraine and schizophrenia is anticipated to drive regional market to grow in the forecast period. Moreover, Asia Pacific is expected to be the fastest growing regional market in the coming years owing to presence of large population awareness regarding the topical pain killer’s products in this region.
The players profiled in the report include AdvaCare Pharma, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Nestlé S.A., Novartis AG, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Topical BioMedics, Inc., Sanofi, and others.
Market Segmentation
Market By Therapeutic Class
Non-opioids
- NSAIDs
- Capsaicin
- Lidocaine
- Methyl salicylate
- Others
Opioids
Market By Type
Prescription Pain Relief
Over the Counter Relief
Market By Formulation
Cream
Spray
Gel
Patch
Others
Market By Distribution Channels
E-commerce drug stores & pharmacies
Retail & grocery stores
Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Topical Pain Killers
1.1. Definition and Scope
1.1.1. Definition of Topical Pain Killers
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Topical Pain Killers Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Topical Pain Killers Market By Therapeutic Class
1.2.3. Topical Pain Killers Market By Type
1.2.4. Topical Pain Killers Market By Formulation
1.2.5. Topical Pain Killers Market By Distribution Channels
1.2.6. Topical Pain Killers Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Regulatory Compliance
3.6. Competitive Landscape, 2019
3.6.1. Player Positioning Analysis
3.6.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Topical Pain Killers Market By Therapeutic Class
4.1. Introduction
4.2. Topical Pain Killers Revenue By Therapeutic Class
4.2.1. Topical Pain Killers Revenue (US$ Mn) and Forecast, By Therapeutic Class, 2016-2027
4.2.2. Non-opiods
4.2.2.1. Non-opiods Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.1.1. NSAIDs
4.2.2.1.1.1. NSAIDs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.1.2. Capsaicin
4.2.2.1.2.1. NSAIDs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.1.3. Lidocaine
4.2.2.1.3.1. NSAIDs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.1.4. Methyl salicylate
4.2.2.1.4.1. NSAIDs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.1.5. Others
4.2.2.1.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-20274.2.3. Opioids
4.2.3.1. Small Molecule Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.1. Fentanyl
4.2.3.2. Small Molecule Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.2.1. Buprenorphine
CHAPTER 5. Topical Pain Killers Market Revenue By Type
5.1. Introduction
5.2. Topical Pain Killers Revenue (US$ Mn) By Type
5.2.1. Topical Pain Killers Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
5.2.2. Prescription Pain Relief
5.2.2.1. Prescription Pain Relief Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Over the Counter Relief
5.2.3.1. Over the Counter Relief Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Topical Pain Killers Market By Formulation
6.1. Introduction
6.2. Topical Pain Killers Revenue (US$ Mn) By Formulation
6.2.1. Topical Pain Killers Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
6.2.2. Cream
6.2.2.1. Cream Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Spray
6.2.3.1. Spray Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Gel
6.2.4.1. Gel Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Patch
6.2.5.1. Patch Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Others
6.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Topical Pain Killers Market By Distribution Channels
7.1. Introduction
7.2. Topical Pain Killers Revenue (US$) By Distribution Channels
7.2.1. Topical Pain Killers Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
7.3. E-commerce drug stores & pharmacies
7.3.1. E-commerce drug stores & pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Retail & grocery stores
7.4.1. Retail & grocery stores Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Topical Pain Killers Market By Country
8.1. North America Topical Pain Killers Overview
8.2. U.S.
8.2.1. U.S. Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016-2027
8.2.2. U.S. Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.2.3. U.S. Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
8.2.4. U.S. Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016-2027
8.3. Canada
8.3.1. Canada Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016-2027
8.3.2. Canada Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.3.3. Canada Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
8.3.4. Canada Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Topical Pain Killers Market By Country
9.1. Europe Topical Pain Killers Market Overview
9.2. U.K.
9.2.1. U.K. Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016-2027
9.2.2. U.K. Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.2.3. U.K. Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
9.2.4. U.K. Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016-2027
9.3. Germany
9.3.1. Germany Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016-2027
9.3.2. Germany Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.3.3. Germany Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
9.3.4. Germany Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016-2027
9.4. France
9.4.1. France Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016-2027
9.4.2. France Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.4.3. France Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
9.4.4. France Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016-2027
9.5. Spain
9.5.1. Spain Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016-2027
9.5.2. Spain Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.5.3. Spain Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
9.5.4. Spain Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016-2027
9.6.2. Rest of Europe Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.6.3. Rest of Europe Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
9.6.4. Rest of Europe Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Topical Pain Killers Market By Country
10.1. Asia Pacific Topical Pain Killers Market Overview
10.2. China
10.2.1. China Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
10.2.2. China Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.3. China Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
10.2.4. China Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
10.3. Japan
10.3.1. Japan Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
10.3.2. Japan Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.3. Japan Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
10.3.4. Japan Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
10.4. India
10.4.1. India Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
10.4.2. India Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.3. India Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
10.4.4. India Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
10.5. Australia
10.5.1. Australia Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
10.5.2. Australia Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.5.3. Australia Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
10.5.4. Australia Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
10.6.2. South Korea Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.6.3. South Korea Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
10.6.4. South Korea Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
10.7.2. Rest of Asia-Pacific Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.7.3. Rest of Asia-Pacific Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
10.7.4. Rest of Asia-Pacific Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Topical Pain Killers Market By Country
11.1. Latin America Topical Pain Killers Market Overview
11.2. Brazil
11.2.1. Brazil Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
11.2.2. Brazil Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.3. Brazil Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
11.2.4. Brazil Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
11.3.2. Mexico Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.3. Mexico Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
11.3.4. Mexico Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
11.4.2. Rest of Latin America Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.3. Rest of Latin America Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
11.4.4. Rest of Latin America Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
CHAPTER 12. Middle East & Africa Topical Pain Killers Market By Country
12.1. Middle East & Africa Topical Pain Killers Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
12.2.2. Saudi Arabia Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.2.3. Saudi Arabia Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
12.2.4. Saudi Arabia Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
12.3. UAE
12.3.1. UAE Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
12.3.2. UAE Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.3.3. UAE Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
12.3.4. UAE Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Therapeutic Class, 2016 - 2027
12.4.2. Rest of Middle East & Africa Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.4.3. Rest of Middle East & Africa Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
12.4.4. Rest of Middle East & Africa Topical Pain Killers Market Revenue (US$ Mn) and Forecast By Distribution Channels, 2016 - 2027
CHAPTER 13. Player Analysis Of Topical Pain Killers
13.1. Topical Pain Killers Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Topical Pain Killers Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. AdvaCare Pharma
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. AdvaCare Pharma 2019 Topical Pain Killers Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. GlaxoSmithKline plc
14.3. Johnson & Johnson Services, Inc
14.4. Nestlé S.A
14.5. Novartis AG
14.6. Pfizer, Inc.
14.7. Sun Pharmaceutical Industries Ltd
14.8. Reckitt Benckiser Group plc.
14.9. Topical BioMedics, Inc
14.10. Sanofi